Science

Vijaya Bhatt Shares Phase II Results on Geriatric-Guided AML Treatment Selection

Vijaya Bhatt/unmc.edu

May 11, 2025, 15:19

Vijaya Bhatt Shares Phase II Results on Geriatric-Guided AML Treatment Selection

Vijaya Bhatt, Professor and Section Leader of Malignant Hematology at the University of Nebraska Medical Center, shared a post on X by Fred and Pamela Buffett Cancer Center, adding:

“Geriatric assessment can be used to define fitness for intensive chemotherapy in older adults with AML. Results of our Phase II trial!”

Quoting Fred and Pamela Buffett Cancer Center’s post:

“New research by Vijaya Bhatt shows pre-treatment geriatric assessment in older adults with AML is feasible and can identify functional impairments to guide treatment intensity selection. A practical approach to personalized care!”

Title: A Phase II Trial of Geriatric Assessment-Guided Selection of Treatment Intensity in Older Adults With AML

Authors: Vijaya R. Bhatt, Christopher S. Wichman, Thuy T. Koll, Alfred L. Fisher, Tanya M. Wildes, Michael Haddadin, Ann M. Berger, James O. Armitage, Sarah A. Holstein, Lori J. Maness, Krishna Gundabolu.

Vijaya Bhatt Shares Phase II Results on Geriatric-Guided AML Treatment Selection

Read the Full Article in the American Journal of Hematology.

More posts featuring Fred and Pamela Buffett Cancer Center.

Alfred L. Fisher AML Ann M. Berger cancer Christopher S. Wichman Fred and Pamela Buffett Cancer Center Geriatric Assessment James O. Armitage Krishna Gundabolu Lori J. Maness Michael Haddadin OncoDaily Oncology Sarah A. Holstein Tanya M. Wildes Thuy T. Koll Vijaya Bhatt Vijaya R Bhatt

Oncologist Near Me – Wafik S. El-Deiry: A Global Leader in Translational Oncology and Cancer Research

In Memory of Bob Marley: His Battle with Melanoma and the Importance of Early Detection

Who From Oncology is Featured in TIME100 Health 2025?

FDA Announces Aggressive Timeline to Scale 1st AI-Assisted Scientific Review Pilot

The Evolving Therapeutic Revolution in Adult Acute Lymphoblastic Leukemia